0.5% povidone iodine irrigation in otorhinolaryngology surgical practice during COVID 19 pandemic

Khan, Mubarak Muhamed; Parab, Sapna Ramkrishna

doi:10.1016/j.amjoto.2020.102687

Cited by 11 publications

(17 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The surgical steps during surgery remained the same.The following precautions were taken during surgery – The surgical and anesthesia team wore Personal protective equipment (PPE), surgical cap, N-95 mask, hood and double gloves. Pre-operatively betadine (0.5%) drops [ 3 ] were instilled in each nostril of patient half an hour before procedure and after induction on the operative table. Surgical tent was created and secured by using barrier draping technique [ 4 ].…”

Section: Case Historymentioning

confidence: 99%

Title of the Article: Paranasal Mucormycosis in COVID-19 Patient

Saldanha

Reddy

Vincent

2021

Indian J Otolaryngol Head Neck Surg

View full text Add to dashboard Cite

There have been a variety of complications reported during and post- COVID infection. Recently, there has been an increase in sporadic cases of paranasal sinus mucormycosis in COVID- 19 patients. We report a case of COVID- 19 patient diagnosed to have orbital apex syndrome secondary to mucormycosis of nose and paranasal sinus requiring emergency endoscopic sinus surgery. Appropriate use of personal protective equipment and safety precautions taken by health care workers prevented the spread of the virus during surgery.

show abstract

Section: Case Historymentioning

confidence: 99%

Title of the Article: Paranasal Mucormycosis in COVID-19 Patient

Saldanha

Reddy

Vincent

2021

Indian J Otolaryngol Head Neck Surg

View full text Add to dashboard Cite

show abstract

“…PVP-I has been directly compared to hydrogen peroxide, another virucidal topic agents, and has been found to be more effective at a variety of dilutions. 25 Given this data, Khan and Parab 26 propose the substitution of 0.5% PVP-I for all irrigation fluid used during otolaryngologic procedures, particularly for the irrigation needed for drilling procedures like mastoidectomies.…”

Section: Discussionmentioning

confidence: 99%

“… 24 These safe to use and readily available PVP-I solutions may reduce the risk of COVID-19 aerosolization and transmission in upper airway mucosal surgery. 22 , 23 , 24 , 25 , 26 , 27 …”

Section: Discussionmentioning

confidence: 99%

“… PVP-I has superior anti-virucidal properties against SARS-CoV-2 than hydrogen peroxide does. Pelletier JS, Tessema B, Frank S, et al 23 Preclinical evaluation of intervention: proof-of-concept Level 4 (case-control) Risk of Bias: Low(authors disclose conflicting interests) Mady LJ, Kubik MW, Baddour K, et al 24 Technical report of intervention (Letter to the editor) Level 5 (mechanism-based reasoning) Risk of Bias: N/A Bidra AS, Pelletier JS, Westover JB, et al 25 Preclinical evaluation of intervention: comparative Level 4 (case-control) Risk of Bias: Low Khan MM, Parab SR. 26 Technical report of intervention Level 5 (mechanism-based reasoning) Risk of Bias: N/A Nasal irrigations have the potential to eliminate viral particles in the nasopharynx. Farrell NF, Klatt-Cromwell C, Schneider JS.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Innovations in otorhinolaryngology in the age of COVID‐19: A systematic literature review

McCarty

Soldatova

Brant

et al. 2022

World j. otorhinolaryngol.-head neck surg.

View full text Add to dashboard Cite

Objective: Otolaryngologists are at increased occupational risk of Coronavirus Disease 2019 (COVID-19) infection due to exposure from respiratory droplets and aerosols generated during otologic, nasal, and oropharyngeal examinations and procedures. There have been a variety of guidelines and precautions developed to help mitigate this risk. While many reviews have focused on the personal protective equipment (PPE) and preparation guidelines for surgery in the COVID-19 era, none have focused on the more creative and unusual solutions designed to limit viral transmission. This review aims to fill that need.Data Sources: PubMed, Ovid/Medline, and Scopus Methods: A comprehensive review of literature was performed on September 28, 2020 using PubMed, Ovid/Medline, and Scopus databases. All English-language studies were included if they proposed or assessed novel interventions developed for Otolaryngology practice during the COVID-19 pandemic. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed.Results: A total of 41 papers met inclusion criteria and were organized into 5 categories ('General Recommendations for Otolaryngologic Surgery', 'Equipment Shortage Solutions', 'Airway Procedures', 'Nasal Endoscopy and Skull Base Procedures', and 'Otologic Procedures'). Articles were summarized, highlighting the innovations created and evaluated during the COVID-19 pandemic. Creative solutions such as application of topical viricidal agents, make-shift mask filters, three-dimensional (3-D) printable adapters for headlights, aerosol containing separation boxes, and a variety of new draping techniques have been developed to limit the risk of COVID-19 transmission.Conclusions: Persistent risk of COVID-19 exposure remains high. Thus, there is an increased need for solutions that mitigate the risk of viral transmission during office procedures and surgeries, especially given that most COVID-19 positive patients present asymptomatically. This review examines and organizes creative solutions that have been proposed and utilized in the otolaryngology. These solutions have a

show abstract

“…In our previous study [ 3 ] about the repurposing of the 0.5% PVP-I nasal drops and gargles, we have proposed that protocolled 0.5% PVP-I nasal drops and oral gargles should be used in current COVID 19 pandemic to limit the spread of SARS – COV-2 from patients to healthcare workers and potentially vice versa. We have also proposed the use of 0.5% PVP-I as an irrigation fluid to reduce the viral load in oropharyngeal, nasal cavities, and middle ear and mastoid during surgeries [ 4 ]. In this study, we report the feasibility and usability of the dispensing of the nasal drops and gargles as primary end points and tolerance as the secondary end point.…”

Section: Introductionmentioning

confidence: 99%